CAC2000 reports nine months net loss of $73.88 million

October 30, 2025

CAC 2000 Limited (CAC)

Unaudited financials for the nine months ended July 31, 2025:

CAC 2000 Limited (CAC), for the nine months ended July 31, 2025, reported a 13% decline in turnover, totaling $655.82 million, compared to $752.81 million in the corresponding period of 2024. Revenue for the third quarter fell by 28%, closing at $222.09 million versus $307.27 million for the comparable quarter in 2024.

Year to date Cost of Sales amounted to $432.09 million (2024: $497.54 million), reflecting a 13% year-over-year decrease. Consequently, gross profit declined by 12% to $223.73 million, compared to $255.27 million for the nine months ended July 31, 2024. For the third quarter, the company recorded gross profit of $76.36 million, down from $106.30 million in the same quarter of 2024.

Selling and Distribution expenses decreased by 83%, closing at $2.49 million (2024: $14.48 million), while General Administrative expenses increased by 7%, rising from $241.99 million in 2024 to $259.21 million in the current period. As a result, total expenses for the nine months ended July 31, 2025, amounted to $261.70 million, a 2% increase compared to $256.47 million reported in 2024. Additonally, Other operating income for the nine months ended July 31, 2025 amounted to $170,692 (2024: $955,521).

Consequently, Operating Loss for the nine months ended July 31, 2025, was $37.80 million, representing a significant deterioration from the loss of $243,362 reported in 2024. For the third quarter, Operating Loss amounted to $7.46 million, compared to a profit of $21.66 million in 2024.

Net Finance Costs totaled $48.40 million, a 27% increase over the $38.21 million recorded in the prior year.

Loss Before Taxation for the nine months ended July 31, 2025, amounted to $86.21 million, a 124% decline relative to the loss of $38.45 million reported in 2024. For the third quarter, Loss Before Taxation was $29.68 million, compared to a profit of $11.72 million in the same period last year.

The tax credit for the nine months ended July 31, 2025 amounted to $12.33 million (2024: tax charge of $3.28 million). As a result, Net Loss for the nine months amounted to $73.88 million, a 77% decline from the loss of $41.74 million reported in 2024. For the third quarter, Net Loss of $29.68 million, compared to a profit of $11.72 million in the prior year.

Consequently, Loss Per Share for the nine months amounted to $0.57 (2024: LPS: $0.32), while Loss Per Share for the quarter totaled $0.23 (2024: EPS: $0.09). The twelve-month trailing LPS was $0.08 and the number of shares used in these calculations was 129,032,258.

Notably, CAC’s stock price closed the trading period on October 24, 2025 at a price of $1.97.

Balance Sheet Highlights

The company’s total assets amounted to $1.44 billion as at July 31, 2025, reflecting an increase of $104.17 million or 8% compared to $1.34 billion reported in the corresponding period of 2024.

This movement was primarily driven by:

  • Trade and Other Receivables, which rose by $240.70 million to $869.65 million (2024: $628.94 million),
  • Inventories amounted to $415.63 million (2024: $545 million),
  • Cash and Cash Equivalents, which grew by $3.44 million to $45.85 million (2024: $42.41 million).

These increases were partially offset by a decline in Property, Plant and Equipment, which fell by $4.78 million to $12.08 million (2024: $16.86 million), and a reduction in Right-of-Use Assets, which decreased by $11.67 million to $20.07 million (2024: $41.74 million).

Shareholders’ equity was $290.95 million (2024: $300.84 million), representing a book value per share of $2.25 (2024: $2.33).

 

 

Disclaimer:

Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.

Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.

2025-10-30T11:19:48-05:00